Biocatalytic synthesis of enantiopure building blocks for pharmaceuticals
- 21 August 2012
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Technologies
- Vol. 10 (1) , e37-e44
- https://doi.org/10.1016/j.ddtec.2012.08.002
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Biocatalysis: Synthesis of Key Intermediates for Development of PharmaceuticalsACS Catalysis, 2011
- Enzymes in the Synthesis of GlycoconjugatesChemical Reviews, 2011
- A Chemoenzymatic Dynamic Kinetic Resolution Approach to Enantiomerically Pure (R)- and (S)-DuloxetineThe Journal of Organic Chemistry, 2011
- Enzymes and Bioconversions of Industrial, Pharmaceutical, and Biotechnological SignificanceOrganic Process Research & Development, 2010
- Biocatalysis: The Road AheadOrganic Process Research & Development, 2010
- Hydrolases: catalytically promiscuous enzymes for non-conventional reactions in organic synthesisChemical Society Reviews, 2010
- Deracemisation methodsCurrent Opinion in Chemical Biology, 2010
- Chemoenzymatic Synthesis of Rivastigmine via Dynamic Kinetic Resolution as a Key StepThe Journal of Organic Chemistry, 2010
- Key Building Blocks via Enzyme-Mediated SynthesisPublished by Springer Nature ,2010
- Chemoenzymatic Synthesis of (Protected) Psymberic AcidEuropean Journal of Organic Chemistry, 2009